Centrex strong buy 0,05 noch! Bio!12%
THURSDAY , FEBRUARY 05, 2004 09:25 AM
TULSA, Okla., Feb 5, 2004 (BUSINESS WIRE) -- Centrex, Inc. (OTCBB:CNEX) today announced that in order to enhance the Company's ability to accelerate the development of the Company's Single Molecule Nucleic Acid Detection (SMD) technology Centrex, Inc., in conjunction with Trifocal LLC, has formed Early Warning Technologies, Inc. Early Warning Technologies will be majority-owned by Centrex and minority-owned by Trifocal LLC. R. Scott Wills, the principal of Trifocal, will serve as CEO of Early Warning Technologies.
Early Warning Technologies will assume the technology assets of Centrex along with certain contractual obligations with Los Alamos and the University of California, and will take over the development and commercialization of the SMD technology from Centrex. This arrangement will allow Centrex to pursue other technology acquisitions and potential joint ventures. Centrex CEO, Thomas R. Coughlin, Jr. M.D. will also serve on the Board of Early Warning Technologies, and will serve as Chief Scientific and Technical Advisor for Early Warning Technologies. The agreement will require shareholder approval
Scott Wills is an experienced corporate executive who has held management positions ranging from start-ups to Fortune 500 companies. He has extensive experience across a broad range of technology industries. As an entrepreneur, Mr. Wills has been involved in the management and funding of both private and public companies and has served as CEO of three other companies. Dr. Coughlin commented, "We are extremely excited about the prospect of working with a person of the caliber of Scott Wills and that Early Warning Technologies will provide the platform necessary to achieve our development goals."
Centrex's SMD technology has been exclusively licensed from Los Alamos National Laboratories and represents advantages over existing DNA and RNA detection methods as well as culture-based test methods. Centrex's detection system is designed to be adaptable to detect a variety of bacterial or viral organisms by recognizing the unique DNA or RNA fingerprint of the organism. The prototype instrument, currently being developed will utilize disposable, multipurpose microfluidics lab cards that incorporate the SMD technology.
For more information, visit the Centrex website at www.centrexcorporation.com or contact 843-971-4848.
Das Kooperationen eingegangen werden müssen ist ja eh klar!
Kannst sie aber direkt beim OTC Bulletin Board nachlesen (unter Headlines):
http://www.otcbb.com/asp/quotes.asp?Sort=4&Quotes=cnex
Die müsste aber die nächste Zeit gut laufen, alleine wegen den Terrorängsten!
ial Detection
Centrex Advances Efforts to Launch SMD System for Viral and Bacterial Detection
Health/Medical Writers / Business Editors
TULSA, Okla.--(BUSINESS WIRE)--CNEX--
Centrex, Inc. (OTCBB:CNEX) today announced that
Micronics, Inc., has advanced the development of an assay that
contains Centrex´s single molecule nucleic acid detection (" SMD" )
technology for application in a laboratory-on-a-card (" lab card" )
format. Micronics reported to Centrex that it has achieved this
important initial milestone which permits lysis and binding reactions
in the lab card format.
SMD technology, in combination with an easy-to-operate lab card
device and integrated reader, is expected to be responsive to the need
for rapid, user friendly and cost effective solutions for point-of-use
analyses of a variety of bacterial and viral organisms.
Centrex´s SMD technology was exclusively licensed from Los Alamos
National Laboratories, and offers important advantages over existing
DNA and RNA detection methods as well as culture-based test methods.
SMD technology eliminates the need for amplification of the target DNA
by recognizing the unique DNA or RNA fingerprint of the target
organism. This reduces the possibility of false positive and negative
test results - common concerns frequently identified with other test
procedures.
As a next step in the development process, Micronics is expected
to integrate the lysing/binding reactions together with SMD using a
biological stimulant, the spores of the bacteria Bacillus globigii.
Bacillus globigii prepared in this manner may be used safely to
simulate Bacillus anthracis (anthrax) spores in the DNA extraction and
binding experiments.
Centrex is focusing commercial efforts in the development of a
product that uses SMD as part of a simultaneous, multi-channel
detection system that is compact, fully automated and capable of
monitoring the presence of biological agents in air, food and water.
Potential additional applications for the SMD technology include
bioterrorism and Homeland Security, food and water processing, blood
supply screening, and general DNA/RNA testing.
Redmond, Washington-based Micronics provides custom lab card
design, development and prototypes systems. The proposed lab card for
the Centrex system is expected to include fully automated on-card
sample preparation, mixing, separation, and analysis. Reagent and
waste storage also are designed to be on card for ease of use and
disposal. Micronics is believed to offer the most sophisticated and
rapid lab card prototyping facility in the world today. For additional
information please visit www.micronics.net.
For more information call Ron Wheet at (843) 971-4848 or visit the
Centrex website at www.centrexcorporation.com.
This press release contains certain forward-looking statements. We
undertake no obligation to publicly update any forward-looking
statement, whether as a result of new information, future events or
otherwise. Forward-looking statements in this document should be
evaluated together with the many uncertainties that affect our
business. Those uncertainties are discussed in the Company´s SEC
filings.
KEYWORD: OKLAHOMA
INDUSTRY KEYWORD: MEDICAL PHARMACEUTICAL MEDICAL MEDICAL DEVICES MEDICAL PRODUCT
SOURCE: Centrex, Inc.
CONTACT INFORMATION:
Centrex, Inc., Tulsa
Ron Wheet, 843-971-4848
Die Story bzw der Trend Bio und Nano ließ bereits ganz andere Werte heftigt steigen. Nur aus Phantasie, aber hier steckt noch was hinter! Die Centrex Inc sind zur falschen Zeit an die Börse gegangen und somit deutlich unter die Räder gekommen. Remember: Sohu, Sina, The Globe, Nanopierce,...
Bis 0,10 sammel ich fröhlich weiter ein, wenn ich Zaster habe!
Gruß an Soros, biste online?
mfg
S.H.
Kursziel , hmmm, könnte schon an die 0,25$ laufen, aber das könnte noch dauern.
Gruß joker
Volumen Taxe
- 0,065
Kauf Orders
Stücke Limit
88.000 0,065
10.000 0,062
20.000 0,061
60.000 0,058
20.000 0,057
Weitere: 7
Best Ask
Taxe Volumen
0,069 -
Verkauf Orders
Limit Stücke
0,069 98.000
0,072 35.000
0,076 33.000
0,078 15.000
0,08 35.000
Weitere: 12